| 1. |
Jiang H, Liang Y, Long K, et al. Postoperative follow-up of a case of atypical morning glory syndrome associated with persistent fetal vasculature[J]. BMC Ophthalmol, 2019, 19(1): 150. DOI: 10.1186/s12886-019-1154-6.
|
| 2. |
Ceynowa DJ, Wickstr?m R, Olsson M, et al. Morning glory disc anomaly in childhood - a population-based study[J]. Acta Ophthalmol, 2015, 93(7): 626-634. DOI: 10.1111/aos.12778.
|
| 3. |
倪穎勤, 趙培泉. 永存原始玻璃體增生癥[J]. 中國斜視與小兒眼科雜志, 2005, 13(4): 185-187. DOI: 10.3969/j.issn.1005-328X.2005.04.021.Ni YQ, Zhao PQ. Persistent hyperplastic primary vitreous[J]. Chinese Journal of Strabismus & Pediatric Ophthalmology, 2005, 13(4): 185-187. DOI: 10.3969/j.issn.1005-328X.2005.04.021.
|
| 4. |
Fei P, Zhang Q, Li J, et al. Clinical characteristics and treatment of 22 eyes of morning glory syndrome associated with persistent hyperplastic primary vitreous[J]. Br J Ophthalmol, 2013, 97(10): 1262-1267. DOI: 10.1136/bjophthalmol-2013-303565.
|
| 5. |
Shastry BS. Persistent hyperplastic primary vitreous: congenital malformation of the eye[J]. Clin Exp Ophthalmol, 2009, 37(9): 884-890. DOI: 10.1111/j.1442-9071.2009.02150.x.
|
| 6. |
Sen P, Wu WC, Chandra P, et al. Retinopathy of prematurity treatment: Asian perspectives[J]. Eye (Lond), 2020, 34(4): 632-642. DOI: 10.1038/s41433-019-0643-4.
|
| 7. |
朱苾丹, 李紹軍. 我國早產兒視網膜病變篩查及治療現狀[J]. 中國斜視與小兒眼科雜志, 2019, 27(3): 44-47. DOI: 10.3969/J.ISSN.1005-328X.2019.03.016.Zhu BD, Li SJ. The status of screening and treatment of retinopathy of prematurity in China[J]. Chinese Journal of Strabismus & Pediatric Ophthalmology, 2019, 27(3): 44-47. DOI: 10.3969/J.ISSN.1005-328X.2019.03.016.
|
| 8. |
Tsang JKW, Liu J, Lo ACY. Vascular and neuronal protection in the developing retina: potential therapeutic targets for retinopathy of prematurity[J]. Int J Mol Sci, 2019, 20(17): 4321. DOI: 10.3390/ijms20174321.
|
| 9. |
Muslubas IS, Hocaoglu M, Arf S, et al. A case of morning glory syndrome associated with persistent hyperplastic primary vitreous and peters' anomaly[J]. GMS Ophthalmol Cases, 2017, 7: 2. DOI: 10.3205/oc000053.
|
| 10. |
Hansen TM, Moss AJ, Brindle NP. Vascular endothelial growth factor and angiopoietins in neurovascular regeneration and protection following stroke[J]. Curr Neurovasc Res, 2008, 5(4): 236-245. DOI: 10.2174/156720208786413433.
|
| 11. |
金姬, 盧一, 馮佳, 等. 視網膜müller細胞條件性基因敲除血管內皮生長因子對氧誘導視網膜病變小鼠的影響[J]. 中華眼底病雜志, 2017, 33(5): 508-512. DOI: 10.3760/cma.j.issn.1005-1015.2017.05.016.Jin J, Lu Y, Feng J, et al. The effect of conditional knocking out vascular endothelial growth factor gene on the mouse model of oxygen induced retinopathy[J]. Chin J Ocul Fundus Dis, 2017, 33(5): 508-512. DOI: 10.3760/cma.j.issn.1005-1015.2017.05.016.
|
| 12. |
Sato T, Wada K, Arahori H, et al. Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity[J]. Am J Ophthalmol, 2012, 153(2): 327-333. DOI: 10.1016/j.ajo.2011.07.005.
|
